Home Compare EW vs SYK
Stock Comparison · Industry comparison · Medical Devices

Edwards Lifesciences vs Stryker: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Edwards Lifesciences carrying a narrow edge on growth. Stryker still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Edwards Lifesciences holds the more constructive position. That puts structure and market broadly in agreement — Edwards Lifesciences's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-05-17

The comparison is mainly decided in growth, with the rest of the profile carrying less weight.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. EW and SYK share the same industry classification.

For a similarity-based comparison, see how Edwards Lifesciences and Stryker each position within their functional peer groups in AssetNext.

Peer-Relative Score
EW
Edwards Lifesciences Corporation
48
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
SYK
Stryker Corporation
43
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: EW vs SYK Profitability 38 31 Stability 50 64 Valuation 40 53 Growth 71 25 EW SYK
Gap Ranking
#1 Growth +46
#2 Stability +14
#3 Valuation +13
#4 Profitability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EW and SYK Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EWSYK Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where EW and SYK each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY EW Neutral · above norm 0th 50th 100th 8 pct gap SYK Neutral · below norm 0th 50th 100th 46th 55th
EW (46th percentile) and SYK (55th percentile) sit at comparable positions within their own 5-year histories. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
Edwards Lifesciences Corporation ranks near the top of the group on growth; Stryker Corporation sits in the weaker half.
Stability
Edwards Lifesciences Corporation sits higher in the group on stability, adding to the overall structural advantage.
Growth — Dominant Gap
EW
71
SYK
25
Gap+46in favour of EW

The clearest distance comes from a stronger growth profile.

What else supports the lead

Edwards Lifesciences Corporation also shows lower market-fundamental divergence, which makes the lead look less detached from the underlying business picture.

What this means for the comparison

Growth gives Edwards Lifesciences Corporation the clearer edge, even though stability and the price setup keep the overall picture from looking clean.

Explore full peer positioning in AssetNext

Break down the EW vs SYK comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-driven comparisons

Explore how EW and SYK each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.